Sauchinone Inhibits the Proliferation and Immune Invasion Capacity of Colorectal Cancer Cells Through the Suppression of PD-L1 and MMP2/MM9

Yiping Lu,Miao Yu,Jinsheng Ye,Yankai Liang,Jianxin Gao,Zhen Ji,Jie Wang
DOI: https://doi.org/10.2174/1871520623666230320125406
IF: 2.8
2023-01-01
Anti-Cancer Agents in Medicinal Chemistry
Abstract:Background Colorectal cancer (CRC) is one of the most common tumors globally and a leading cause of cancer-related death. In China, CRC is the third most common cancer type. Sauchinone is known to exhibit anti-tumor and anti-inflammatory activity, but its effects on CRC have not been investigated to-date. Objective To investigate the effects of Sauchinone on CRC development and metastasis and its underlying mechanism(s) of action. Methods SW480 and HCT116 cells were treated with a range of concentrations of Sauchinone. Cell proliferation was measured using EDU assays and flow cytometry. Results Treatment with 50 & mu;M Sauchinone decreased the expression of MMP2 and MMP9 and downregulated PD-L1 expression (PD-1/PD-L1) leading to checkpoint inhibition. Sauchinone treatment also enhanced the cytotoxicity of SW840 and HCT116 cells co-cultured with CD8(+) T cells. The overexpression of PD-L1 rescued the anti-proliferative and cytotoxic effects of Sauchinone in both types. Conclusions We show that Sauchinone suppresses CRC cell growth through the downregulation of MMP2 and MM9 expression and PD-1/PD-L1 mediated checkpoint inhibition. Collectively, these data highlight the promise of Sauchinone as a future anti-CRC therapeutic.
What problem does this paper attempt to address?